These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27862179)

  • 1. The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.
    Okkerse P; van Amerongen G; de Kam ML; Stevens J; Butt RP; Gurrell R; Dahan A; van Gerven JM; Hay JL; Groeneveld GJ
    Br J Clin Pharmacol; 2017 May; 83(5):976-990. PubMed ID: 27862179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs.
    Siebenga PS; van Amerongen G; Okkerse P; Denney WS; Dua P; Butt RP; Hay JL; Groeneveld GJ
    Eur J Pain; 2019 Jul; 23(6):1129-1140. PubMed ID: 30793411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.
    van Amerongen G; Siebenga P; de Kam ML; Hay JL; Groeneveld GJ
    Eur J Pain; 2018 Aug; 22(7):1331-1342. PubMed ID: 29635857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na
    Siebenga P; van Amerongen G; Hay JL; McDonnell A; Gorman D; Butt R; Groeneveld GJ
    Clin Transl Sci; 2020 Mar; 13(2):318-324. PubMed ID: 31642607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models.
    Loudon P; Siebenga P; Gorman D; Gore K; Dua P; van Amerongen G; Hay JL; Groeneveld GJ; Butt RP
    Br J Clin Pharmacol; 2018 Feb; 84(2):301-309. PubMed ID: 29178434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam as an active placebo in 3 fentanyl-validated nociceptive pain models.
    Prosenz J; Gustorff B
    Pain; 2017 Jul; 158(7):1264-1271. PubMed ID: 28338566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA
    van Amerongen G; Siebenga PS; Gurrell R; Dua P; Whitlock M; Gorman D; Okkerse P; Hay JL; Butt RP; Groeneveld GJ
    Br J Anaesth; 2019 Aug; 123(2):e194-e203. PubMed ID: 30915991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.
    Schaffler K; Nicolas LB; Borta A; Brand T; Reitmeir P; Roebling R; Scholpp J
    Br J Clin Pharmacol; 2017 Jul; 83(7):1424-1435. PubMed ID: 28139023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects.
    van Esdonk MJ; Lindeman I; Okkerse P; de Kam ML; Groeneveld GJ; Stevens J
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):573-580. PubMed ID: 30043517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic efficacy of tramadol, pregabalin and ibuprofen in menthol-evoked cold hyperalgesia.
    Altis K; Schmidtko A; Angioni C; Kuczka K; Schmidt H; Geisslinger G; Lötsch J; Tegeder I
    Pain; 2009 Dec; 147(1-3):116-21. PubMed ID: 19762153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.
    Olesen SS; Graversen C; Bouwense SA; van Goor H; Wilder-Smith OH; Drewes AM
    PLoS One; 2013; 8(3):e57963. PubMed ID: 23469256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults.
    Hijma HJ; Siebenga PS; de Kam ML; Groeneveld GJ
    Pain Med; 2021 Aug; 22(8):1814-1826. PubMed ID: 33543763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analgesic effect of codeine as compared to imipramine in different human experimental pain models.
    Enggaard TP; Poulsen L; Arendt-Nielsen L; Hansen SH; Bjørnsdottir I; Gram LF; Sindrup SH
    Pain; 2001 May; 92(1-2):277-82. PubMed ID: 11323149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model.
    Prabhavathi K; Chandra US; Soanker R; Rani PU
    Indian J Pharmacol; 2014; 46(5):475-9. PubMed ID: 25298573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties.
    Okkerse P; Hay JL; Sitsen E; Dahan A; Klaassen E; Houghton W; Groeneveld GJ
    Br J Clin Pharmacol; 2017 Apr; 83(4):751-763. PubMed ID: 27987228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: a human experimental study.
    Arendt-Nielsen L; Andresen T; Malver LP; Oksche A; Mansikka H; Drewes AM
    Clin J Pain; 2012 Sep; 28(7):623-7. PubMed ID: 22156892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery.
    Okkerse P; Alvarez-Jimenez R; Hay JL; Tehim A; Kumar R; de Kam ML; Groeneveld GJ
    Eur J Pain; 2017 Mar; 21(3):494-506. PubMed ID: 27651026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A translational study of the effects of ketamine and pregabalin on temporal summation of experimental pain.
    Arendt-Nielsen L; Mansikka H; Staahl C; Rees H; Tan K; Smart TS; Monhemius R; Suzuki R; Drewes AM
    Reg Anesth Pain Med; 2011; 36(6):585-91. PubMed ID: 21941220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.